European Haemophilia Consortium: Day 1 At EHC Conference 2025 In Vienna – What A Start
European Haemophilia Consortium (EHC) posted on LinkedIn:
”Day 1 at EHC Conference 2025 in Vienna – What a Start
We kicked off with insights into haemophilia care in Austria, celebrating six decades of advocacy from Österreichische Hämophilie Gesellschaft (ÖHG), the Austrian Haemophilia Society, and learning from their national registry and treatment guidelines.
A powerful session on women’s health and bleeding disorders broke down barriers with discussions on diagnosis, menopausal management, and inspiring patient perspectives from symptomatic carriers.
The afternoon dove deep into von Willebrand Disease, exploring family mental health, the latest in genetics and screening, and a sneak peek at future treatments.
The day wrapped up with our General Assembly, where EHC National Member Organisation representatives came together for important discussions and decisions about our community’s future.
Thank you to our brilliant chairs, speakers, and all attendees. Looking forward to tomorrow’s sessions.”
Keep up with Hemostasis Today.
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin
-
Jan 12, 2026, 15:07Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights